Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies
- PMID: 35514930
- PMCID: PMC9058261
- DOI: 10.1039/d0ra09051d
Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies
Abstract
Dihydrofolate reductase (DHFR) inhibitors, as antibacterial agents, contain pyrimidine, pteridine, and azine moieties among many other scaffolds. Folic acid (FA), with a pteridine ring and amine group, was used as our focus scaffold, which was then conjugated with sulfonamides to develop new conjugates. The novel synthesized conjugates were characterized using infrared spectroscopy, and 1H and 13C nuclear magnetic resonance (NMR) spectral studies and consequently screened for antimicrobial activities against bacterial strains with ampicillin as a positive control. Compound DS2 has the highest zone of inhibition (36.6 mm) with a percentage activity index (%AI) value of 122.8% against S. aureus and a minimum inhibitory concentration (MIC) of 15.63 μg mL-1. DHFR enzyme inhibition was also evaluated using the synthesized conjugates through in vitro studies, and inhibition assays revealed that compound DS2 exhibited a 75.4 ± 0.12% (mean ± standard error of the mean (SEM)) inhibition, which is comparable with the standard DHFR inhibitor trimethoprim (74.6 ± 0.09%). The compounds attached to the unsubstituted aryl moiety of the sulfonamides revealed better inhibition against the bacterial strains as compared to the methyl substituted aryl sulfonamides. Molecular docking studies of the novel synthesized conjugates were also performed on the DHFR enzyme to identify the plausible binding modes to explore the binding mechanisms of these conjugates.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
We wish to confirm that there are no known conflicts of interest associated with this publication.
Figures




Similar articles
-
Design, synthesis, and biological evaluation of novel N 4 -substituted sulfonamides: acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors.BMC Chem. 2019 Jul 11;13(1):91. doi: 10.1186/s13065-019-0603-x. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384838 Free PMC article.
-
Molecular modeling, synthesis and biological evaluation of caffeic acid based Dihydrofolate reductase inhibitors.BMC Chem. 2024 Dec 18;18(1):242. doi: 10.1186/s13065-024-01355-4. BMC Chem. 2024. PMID: 39696655 Free PMC article.
-
Design, Synthesis, and Antimicrobial Evaluation of a New Series of N-Sulfonamide 2-Pyridones as Dual Inhibitors of DHPS and DHFR Enzymes.ACS Omega. 2020 Apr 28;5(18):10401-10414. doi: 10.1021/acsomega.0c00280. eCollection 2020 May 12. ACS Omega. 2020. PMID: 32426597 Free PMC article.
-
New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study.Bioorg Chem. 2020 Jun;99:103438. doi: 10.1016/j.bioorg.2019.103438. Epub 2019 Nov 13. Bioorg Chem. 2020. PMID: 31796216
-
Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.Molecules. 2020 Jun 2;25(11):2593. doi: 10.3390/molecules25112593. Molecules. 2020. PMID: 32498469 Free PMC article.
Cited by
-
Synthesis, characterization, in silico molecular docking, and antibacterial activities of some new nitrogen-heterocyclic analogues based on a p-phenolic unit.RSC Adv. 2022 Apr 26;12(20):12607-12621. doi: 10.1039/d2ra01794f. eCollection 2022 Apr 22. RSC Adv. 2022. PMID: 35496342 Free PMC article.
-
Exploring the Potential of New Benzamide-Acetamide Pharmacophore Containing Sulfonamide as Urease Inhibitors: Structure-Activity Relationship, Kinetics Mechanism, and In Silico Studies.ACS Omega. 2023 Nov 22;8(48):46165-46181. doi: 10.1021/acsomega.3c07275. eCollection 2023 Dec 5. ACS Omega. 2023. PMID: 38075833 Free PMC article.
-
Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies.Pharmaceuticals (Basel). 2022 Mar 7;15(3):316. doi: 10.3390/ph15030316. Pharmaceuticals (Basel). 2022. PMID: 35337114 Free PMC article.
-
Folate Conjugated Polyethylene Glycol Probe for Tumor-Targeted Drug Delivery of 5-Fluorouracil.Molecules. 2022 Mar 9;27(6):1780. doi: 10.3390/molecules27061780. Molecules. 2022. PMID: 35335144 Free PMC article.
-
Synthesis, characterization and biological profile of some new dihydropyrimidinone derivaties.Heliyon. 2024 Dec 12;11(1):e41152. doi: 10.1016/j.heliyon.2024.e41152. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39811294 Free PMC article.
References
LinkOut - more resources
Full Text Sources